The global CRISPR
technology market size was estimated at USD 5.72 billion in 2024 and is
expected to surge about USD 26.22 billion by 2034, expanding at a CAGR of
16.54% during the forecast period from 2025 to 2034. The growth of the market
is driven by rising advancements in technology and increasing R&D.
Get All the Details in Our Solutions – Download Brochure:
Market Overview
CRISPR technology is a revolutionary tool
in genetic engineering and molecular biology that helps researchers to easily
cut DNA and replace sequences with extreme accuracy and precision. This tool
has been playing a crucial role in the development of gene therapy because
it allows researchers to track gene functions as well as edit them. CRISPR
technology also applied in creating genetically modified crops. The rising
prevalence of chronic diseases across the world is boosting the demand for gene
therapies, further impacting the CRISPR technology market.
The increasing awareness amongst people
regarding gene therapy and its benefits is contributing to market growth.
Research and development activities for gene therapy are rising with increasing
public and private investments. Moreover, continuous R&D activities to
explore applications and improve the accuracy and reliability of CRISPR
technology impact the market. Market players are collaborating with academic
and research institutions to commercialize CRISPR technology.
You can place an order or ask any questions, please feel
free to contact us at sales@towardshealthcare.com
Major Trends in the CRISPR Technology Market
Rising Investment in Genomics and Gene Therapies:
The prevalence of chronic diseases, like genetic disorders
and cancer, is on the rise across the world. This has prompted initiatives for
extensive study of genes to understand disease patterns and develop novel drugs
and treatments. An incredible rise in investments in research and development
activities, especially government funding, is a major factor driving the growth
of the market.
For instance, the Australian Government approved the NHMRC
Grant Program 2024-25 for the next phase of Australian Genomics. Under the
program, US$ 5.9 million is allocated for Australian Genomics,
which will support researchers as well as roll out genomic
technologies into the Australian health system. In addition, the rising
investments to develop gene therapies for cancer are boosting market growth.
According to the American Society of Gene & Cell Therapy, in Q2 of 2024,
about 4,047 cell, gene, and RNA therapies were in the pipeline, of which
51% were gene therapies.
Technological Advancements:
Rising advancements in CRISPR technology drive the growth of
the CRISPR technology market. Innovations in molecular biology, biotechnology,
and delivery methods are enhancing the capabilities of CRISPR technology.
Improvements in viral vectors directly impact the efficiency and precision of
CRISPR technology. In vivo CRISPR helps eliminate the need to separate and
modify cells outside the body by allowing direct targeting. Technological
advances in vivo techniques help widen the scope of treatment options for
genetic disorders and other diseases. Such technological advancements are
boosting CRISPR technology’s efficacy and increasing its application area.
Demand for Personalized Medicine:
The demand for personalized medicine is rising rapidly due
to the growing awareness amongst people regarding the benefits
of precision medicine. The precise and targeted gene alterations are
made possible by CRISPR technology, which further helps
to develop personalized medicine. The ability of personalized medicine
to provide customized treatments suitable to an individual’s specific genetic
composition proves to be a viable treatment option. A rise in research and
development activities focusing on personalized medicine, where CRISPR
technology is a mainstay, contributing to market expansion.
Get the latest insights on
healthcare industry segmentation with our Annual Membership:
Regional Insights
North America: The Epicenter of CRISPR Technology
Development
North America dominated the market with the largest share in
2024. This is mainly due to its well-established infrastructure for research
and robust biotechnology and healthcare industries. The rise in investments in
genetic research activities by biotechnology companies and academic and
research institutions further bolstered the regional market growth. The region
is likely to continue its growth trajectory in the coming years due to the
presence of leading biotechnology companies that provide gene editing services,
genome sequence, and gene therapies. The increasing prevalence of chronic
diseases is prompting innovations in treatments for rare genetic disorders and
cancer.
The U.S. and Canada play a major role in the growth of the
North American CRISPR technology market. The strong emphasis on research and
development activities and regulatory support to commercialize CRISPR
technology contribute to market growth. There is also high demand for gene
therapies, which contributes to market expansion.
Asia Pacific: The Fastest-Growing Region
Asia Pacific is likely to witness the fastest growth over
the studied period. The rapid expansion of the biotechnology industry is
expected to boost market growth. Countries like China, India, and Japan are
expected to lead the Asia Pacific CRISPR technology market. The Chinese
government is investing heavily in research and development of CRISPR
technology to explore its applications, especially in medicine and agriculture.
The regulatory environment in the country is favorable for genetic research.
The strong support from the government for the development of gene therapy and
personalized medicine will propel the market in Japan. In addition, the Indian
government is focusing on improving healthcare and research infrastructure,
contributing to market growth.
Elevate your healthcare strategy
with Towards Healthcare. Enhance efficiency and drive better outcomes—schedule
a call today:
Market Segmentation
Product & Services Insights
The product segment led the CRISPR technology market in
2024. Products like CRISPR kits and enzymes are necessary for the creation of
disease models that are then used for scientific research. Researchers can
replicate the diseased part in the cells by introducing certain genetic
abnormalities. In addition, these products play a crucial role in gene editing.
The rise in research activities on diseases contributes to segmental growth.
The services segment is predicted to witness the fastest
growth in the coming years. Researchers are able to conduct proper and
functional genomic studies due to CRISPR screening services. These services
help in the methodical targeting and modification of individual genes. This
further helps researchers identify genes that are important for certain
biological pathways, illnesses, or processes.
Application Insights
The discovery & development segment held the largest
share of the market in 2024. The rise in the number of chronic disease cases
has increased the demand for novel drugs and treatments. The complete
evaluation of genetics, gene modification of cellular phenotypes, and CRISPR
screening help in drug discovery. CRISPR technology plays a key role in gene
editing in specific cell lines, helping researchers to identify potential drug
targets. The increase in government investments in drug discovery and
development augmented the segment.
The agriculture segment is projected to expand at the
fastest rate during the forecast period. The development of crops that are
resistant to pests and grow quicker is possible due to CRISPR technology. The
genetic alterations for lessening chemical pesticide dependency are being
worked on. CRISPR technology helps to improve crop traits such as quality and
make crops tolerant to herbicides. It also helps to increase the nutritional
value of food produced.
End-user Insights
The pharmaceutical & biotechnology companies segment
dominated the market in 2024. These companies constantly participate in
research and development activities and utilize CRISPR technology for different
purposes. The alteration of immune cells for immunotherapy to improve their
ability to treat cancer is possible because of CRISPR technology. This
technology is a key factor driving
innovation in the pharmaceutical and biotechnology industries. On the
other hand, the academic & research institutions segment is expected to
grow rapidly during the projection period. The rising engagement of these
institutes in research studies to identify underlying causes of specific
diseases supports segmental growth.
Competitive Landscape & Major Breakthroughs in the
Market
The CRISPR technology market is evolving rapidly. The market
is highly competitive, with numerous players making efforts to bring
innovations to the market. Some of the prominent players operating in the
market are Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies,
Inc., Genscript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine,
Intellia Therapeutics, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc.,
Lonza Group, Ltd., Danaher Corporation, PerkinElmer, Inc., Hera Biolabs,
OriGene Technologies, Inc., Cellecta, Inc., Mammoth Biosciences, Inc., Applied
StemCell, New England Biolabs Inc., ToolGen Inc., GeneCopoeia, Inc., and
others.
Browse More Insights of Towards Healthcare:
• Cell Therapy Manufacturing Market
Size:
• Biosimilars Market Size:
• AI in Genomics Market Size:
• Liquid Biopsy Market Size:
• Europe Cell Culture Media Market Size:
• Biomarkers Market Size:
• Cell and Gene Therapy Market Size:
• Biopharmaceuticals Market Size:
• Cholera Vaccines Market Size:
• Automated and Closed Cell Therapy
Processing Systems Market Size:
Recent Developments
• In January 2025, Researchers at Aarhus
University, Denmark, announced the development of a new method to achieve
precise and complex genetic manipulations. This new Triple-Action CRISPR
Technology will enable simultaneous gene activation, repression, and deletion
in Primary Human T Cells.
• In December 2024, engineers at the
University of Southern California (USC) developed a new CRISPR toolkit for
remote-controlled genome editing. This is a major breakthrough for the CRISPR
technology applications.
Segments Covered in the Report
By Product & Services
• Products
• CRISPR Kits & Enzymes
• CRISPR Libraries
• Other Products (design tools,
antibodies, other reagents)
• Services
• gRNA Design & Vector
Construction
• Cell Line Engineering
• Screening Services
• Other Services (Epigenome
Editing and Transcriptional Activation)
By Application
• Drug Discovery & Development
• Agriculture
• Other Applications (biofuels, veterinary)
By End-user
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others (CROs & CDMOs)
By Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa (MEA)
Discover
our detailed Table of Contents (TOC) for the CRISPR Technology Market @
Invest in Our
Premium Strategic Solution @
You can place an order or ask any questions, please feel free to
contact us at sales@towardshealthcare.com
Gain access to the latest insights and
statistics in the healthcare industry by subscribing to our Annual Membership.
Stay updated on healthcare industry segmentation with detailed reports, market
trends, and expert analysis tailored to your needs. Stay ahead of the curve
with valuable resources and strategic recommendations. Join today to unlock a wealth
of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription
About Us
Towards Healthcare is a leading global
provider of technological solutions, clinical research services, and advanced
analytics to the healthcare sector, committed to forming creative connections
that result in actionable insights and creative innovations. We are a global
strategy consulting firm that assists business leaders in gaining a competitive
edge and accelerating growth. We are a provider of technological solutions,
clinical research services, and advanced analytics to the healthcare sector,
committed to forming creative connections that result in actionable insights
and creative innovations.
Browse our
Brand-New Journals:
Precedence Research | Statifacts | Towards Packaging | Towards
Automotive | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire
For Latest Update Follow Us:
link